| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.34 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.35 | 0.06 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |